Is CME a buy according to AI stock analysis?

CME AI stock analysis does not label the stock a universal buy because CME has a high-quality derivatives franchise but depends on volumes, volatility, regulation, product pricing, and valuation. The decision depends on whether an investor believes CME can keep premium margins and data economics through quieter markets.

What is the CME AI stock forecast?

The CME AI stock forecast uses scenarios rather than a certain target. The bullish case is $335 to $365, the base case is $265 to $295, and the bearish case is $190 to $215, with the ranges driven by EPS growth, volume durability, market data growth, and valuation-multiple assumptions.

What technical levels matter for CME?

The CME technical levels that matter are support around $255 to $260 and the 50-day moving average near $252.82, with the 200-day moving average near $278.56 as the first major resistance and $290 to $300 above it. A close below $252.82 would weaken the short-term repair, while a reclaim of $278.56 would improve the recovery pattern.

Can AI predict CME stock price?

No, AI cannot reliably predict stock prices. AI can organize CME filings, volume releases, market data, technical levels, valuation math, and risk paths into a repeatable framework, but volatility regimes, earnings surprises, regulation, and competition can change the outcome.

How should I use this CME AI trading strategy?

Use this CME AI trading strategy as a checklist for monitoring trend, valuation, earnings, average daily volume, market data revenue, rate-product activity, new product traction, CEO transition execution, and risk controls. It should support your own research process and should not replace position sizing, stop planning, tax considerations, or professional advice.

What is the main bull case for CME Group?

The main bull case is that CME keeps compounding through benchmark futures and options, clearing scale, record market data revenue, international growth, margin efficiencies, and new Single-Stock, Compute, and 24/7 products, all supported by a record first half of 2026.

What is the main bear case for CME?

The main bear case is that CME earnings are closer to a volume peak than investors expect, with lower volatility, the CFTC stay on 24/7 crude, fee pressure, perpetual futures and prediction market competition, and regulatory scrutiny reducing growth and the valuation multiple.

CME Group Inc. research snapshot

CME AI Stock Analysis

CME AI stock analysis reads CME Group Inc. as a high-quality derivatives exchange and clearing franchise with benchmark futures, options, market data, and capital-efficient margin services. At the August 2, 2026 data cutoff, CME closed at $267.79 on July 31, 2026 with a market capitalization near $96.29 billion. The company reported record first-half 2026 results with Q2 revenue of $1.7 billion, record market data revenue of $238 million up 20%, and a 6.1% share price jump on the July 22 report, but the stock still trades below its 200-day moving average and carries a premium earnings multiple, so this page uses scenario ranges rather than a certain price prediction. This is informational research and not investment advice.

Current price

$267.79

Market cap

$96.29 billion

AI score

77 / 100

Rating

Record H1 results, strong volumes and market data, premium valuation with trend repair still in progress

Trend status

Reclaimed the 50-day average but still below the 200-day average, with warm RSI

Data cutoff (updated monthly)

August 4, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness: A-level information richness. CME has long public filings, audited annual data, detailed quarterly releases, monthly volume reports, management disclosures, analyst coverage, and multiple third-party quote and financial datasets.
bias Check: The main AI bias risk is over-weighting CME as an obvious best-in-class exchange after record first-half volumes while under-weighting volume cyclicality, rate-cycle normalization, the CFTC stay on 24/7 crude oil, perpetual futures competition, fee sensitivity, client concentration, and management transition risk.
ai Confidence: High for current price, market cap math, share count, revenue, net income, EPS, cash, debt, free cash flow, Q2 2026 results, and July 2026 analyst consensus. Medium for technical levels because static pages can age quickly after sharp moves.
investment Certainty: Medium. CME is easier to underwrite than most financial technology companies, but investment certainty is lower than data confidence because volumes, volatility, rates, clearing rules, perpetual futures competition, and valuation multiples can shift quickly.

Quick verdict table

Dimension	Conclusion	Confidence
Business quality	CME operates benchmark futures, options, clearing, cash markets, and market data services across rates, equity indexes, FX, energy, agriculture, metals, and crypto, with TTM revenue of $6.77 billion and a TTM net margin above 63%.	High
Moat	Moat comes from liquidity network effects, benchmark contracts, clearing scale, regulatory licenses, capital efficiencies, proprietary data, and deep workflow integration across the world risk transfer complex.	High
Management	Terry Duffy remains Chairman and CEO, and President and CFO Lynne Fitzpatrick is the announced successor who was publicly congratulated on the promotion on the Q2 call, making the leadership handoff a key planned watch item.	Medium-high
Financial trend	Q2 2026 revenue of $1.7 billion rose 1% to a record second quarter, market data revenue hit a record $238 million up 20%, adjusted EPS was $2.99, and first-half adjusted EPS climbed 10% on the strongest H1 in company history.	High
Valuation	At $267.79, CME traded near 22.7x TTM EPS, 21.6x forward EPS, 14.3x sales, 22.9x trailing free cash flow, and a 4.24% dividend yield that includes a special dividend.	High
Technical trend	The stock closed above its 50-day average near $252.82 but below its 200-day average near $278.56, with RSI near 66.87, so the chart is repairing rather than confirmed bullish.	Medium-high
Risk level	Main risks are lower volatility, lower rate-product activity, fee pressure, the CFTC stay on 24/7 crude, perpetual futures competition, client concentration, and execution risk around new products.	Medium-high
AI confidence	High for filings, releases, and math that cross-validated across the Q2 release, StockAnalysis, and the earnings transcript. Medium for forward returns because activity, product mix, rules, and valuation can change.	High data confidence
Investment certainty	Medium certainty. CME is a quality market infrastructure franchise, but this page is a research framework, not a buy or sell instruction.	Medium

CME AI stock forecast

CME AI Stock Forecast Scenarios

The CME AI stock forecast uses scenario math around the July 31, 2026 close of $267.79 and TTM diluted EPS of $11.79. A three-year EPS and exit multiple framework produced a bullish value near $351, a base value near $281, and a bearish value near $200 before any share count change. These outputs show that upside depends on durable volumes, continued market data growth, new product traction, and the market keeping a premium multiple on CME cash generation.

Bullish case

$335 to $365

More likely if interest-rate, equity-index, crypto, agriculture, and international volumes remain elevated, Single-Stock and Compute futures scale, market data keeps compounding, and the CEO transition stays smooth.

Base case

$265 to $295

More likely if ADV normalizes from record H1 levels, revenue grows in the high single digits, operating margins stay near 69% adjusted, and the market values CME near a high-teens to low-20s forward earnings multiple.

Bearish case

$190 to $215

More likely if volatility cools, rate futures activity slows, the CFTC stay spreads to other 24/7 products, perpetual futures or prediction markets fragment volume, and investors compress the earnings multiple.

CME AI technical analysis

CME AI Technical Analysis

CME AI technical analysis is cautiously constructive as of the August 2, 2026 data cutoff. The stock closed at $267.79 on July 31, 2026, above its 50-day moving average near $252.82 but below its 200-day moving average near $278.56, with RSI near 66.87, a beta near 0.28, and a 52-week range of $218.31 to $329.16.

Level	Value	Why it matters
Current price	$267.79	July 31, 2026 closing price used for this static page.
Near support	$255 to $260	This zone sits just below the recent breakout area and is the first place to watch for buyer defense on any pullback.
50-day moving average	$252.82	The stock reclaimed this level, and a hold above it keeps the near-term repair attempt alive.
Secondary support	$240 to $248	A break below the 50-day average would point back toward the early-July low area rather than a clean recovery.
Near resistance	$278 to $282	The 200-day moving average near $278.56 is the first key repair level that buyers need to reclaim.
Major resistance	$290 to $300	Above the 200-day line, the $290 to $300 zone and the 52-week high of $329.16 are the larger trend references.
Momentum	RSI 66.87	RSI is warm and approaching overbought after the post-earnings rally, so the setup needs follow-through rather than chasing.
Volume	About 2.77 million average shares	The 20-day average volume gives a liquidity reference for judging whether a breakout or breakdown has sponsorship.
Volatility	Beta 0.28	CME has shown low market beta, but company-specific volume, regulation, and product-pricing headlines can still move the stock.
Invalidation	Close below $252, then $240	A close below the 50-day moving average near $252.82 would weaken the recovery attempt. A close below $240 would signal a deeper trend failure.

CME AI trading strategy

CME AI Trading Strategy Framework

The CME AI trading strategy is a rules-based framework for a derivatives exchange, clearing, and market data stock. It is not personalized advice and should be paired with live chart data, position sizing, filings, earnings dates, monthly volume reports, volatility data, and a defined invalidation level.

Trend-following setup

Watch for CME to hold the $255 to $260 support band and the 50-day average near $252.82, then reclaim the 200-day average near $278.56 with improving volume before treating the repair as confirmed.

A close below $252.82 or a failed reclaim after the next earnings report should invalidate the near-term trend setup.

Mean-reversion setup

If CME pulls back without a thesis break, compare the price move with ADV, rate volatility, equity-index volume, cryptocurrency volume, market data revenue, and management commentary before acting.

Do not treat low beta as a substitute for a stop because exchange operators can rerate when volume, regulation, or competition expectations change.

Fundamental monitor

Track clearing and transaction fees, total average rate per contract, market data revenue, non-U.S. ADV, margin savings, Single-Stock and Compute futures traction, cash and debt, buybacks, dividends, and CEO transition execution.

Reduce confidence if growth is concentrated in temporary volatility spikes while recurring data revenue, clearing economics, or product share weaken.

Investment research summary

Four-master Research Compression

Business essence

CME helps institutions, asset managers, banks, hedge funds, market makers, corporates, farmers, energy firms, and retail brokers hedge and trade risk through standardized futures, options, clearing, cash markets, and market data.

Moat

The moat is built from benchmark contracts, deep liquidity pools, central clearing, regulatory permissions, margin offsets, proprietary data, global distribution, and the cost of moving risk-management workflows away from established venues.

Munger risk inversion

The thesis fails if volatility and rate uncertainty normalize sharply, fee increases meet resistance, regulators stay or change 24/7 and market-structure rules, clients shift activity elsewhere, or perpetual futures and prediction markets fragment volume.

Management

Management has delivered record first-half results and strong capital returns under Terry Duffy, while Lynne Fitzpatrick brings finance and corporate development experience into the planned CEO role. The handoff is orderly but still a key watch item.

Industry trend

CME sits inside long-running demand for derivatives, clearing, collateral efficiency, market data, global risk transfer, 24-hour access, crypto risk products, and new event, Single-Stock, and Compute futures contracts.

Valuation and margin of safety

The current price is well below the 2026 high but still prices CME as a premium compounding exchange, so margin of safety depends on volume durability, pricing power, and the market keeping a quality multiple.

Source-backed data

CME Data Table

Every metric below includes a source and last verification date.

Metric	Value	Source	Last verified
CME price	$267.79 at the July 31, 2026 close	StockAnalysis real-time quote	July 31, 2026
Market capitalization	$96.29 billion, verified as $267.79 x 359.58 million shares with 0.00% deviation	financial_rigor.py market cap verification and StockAnalysis	July 31, 2026
Q2 2026 revenue and EPS	Revenue of $1.7 billion up 1%, GAAP diluted EPS of $2.88, and adjusted diluted EPS of $2.99	CME Group Q2 2026 financial results	July 22, 2026
Q2 2026 activity	Q2 ADV of 29.8 million contracts, the third highest quarterly ADV ever, with non-U.S. ADV of 9.1 million and an average rate of $0.678 per contract	CME Group Q2 2026 financial results and earnings call	July 22, 2026
Q2 2026 market data revenue	Record market data revenue of $238 million, up 20% year over year, the eighth consecutive record quarter	CME Group Q2 2026 earnings release and call	July 22, 2026
H1 2026 performance	Volume up 10%, revenue up 8%, and adjusted diluted EPS up 10%, described by management as the strongest first half in CME history	CME Group Q2 2026 earnings call	July 22, 2026
FY2025 revenue and net income	$6.521 billion revenue and $4.021 billion net income to common, cross-checked against StockAnalysis	CME Group FY2025 financial results and StockAnalysis	July 28, 2026
Cash and debt	Cash and short-term investments of $2.276 billion and total debt of $3.424 billion at June 30, 2026; the Q2 release reported about $2.3 billion in cash and $3.4 billion in debt	StockAnalysis balance sheet and CME Q2 2026 release	July 28, 2026
Valuation ratios	22.71x TTM PE, 21.55x forward PE, 14.25x sales, 22.86x price to free cash flow, and 4.24% dividend yield by tool check	StockAnalysis statistics and financial_rigor.py valuation check	August 1, 2026
Dividend	Annual dividend of $11.35 including the March 2026 special dividend of $7.45, with a regular quarterly dividend of $1.30 paid in June 2026	StockAnalysis dividend history	August 1, 2026
Technical snapshot	50-day average $252.82, 200-day average $278.56, RSI 66.87, beta 0.28, 20-day average volume near 2.77 million shares	StockAnalysis stock price statistics	July 31, 2026
Analyst consensus	Buy with an average price target of $283.93 across 16 analysts, low $230 and high $330, median $286	StockAnalysis forecast and analyst ratings	July 23, 2026
Recent analyst target updates	JPMorgan $249 to $250, RBC $302, UBS $260, Piper Sandler $295, KBW $285, Morgan Stanley $324 to $330, BofA $226 to $230	StockAnalysis forecast latest forecasts	July 23, 2026
2026 and 2027 consensus estimates	FY2026 revenue estimate $7.04 billion with adjusted EPS $12.27, and FY2027 revenue estimate $7.36 billion with adjusted EPS $12.94	StockAnalysis forecast financial forecast	July 23, 2026
New product launches	Single-Stock futures on 55 U.S. names launched July 27, 2026, 24/7 1-Ounce Gold futures launched late July with about 15,000 contracts in the first weekend, and Compute futures with Silicon Data planned for later in 2026	PRNewswire, CNBC, and CME Q2 2026 earnings call	July 27, 2026
Regulatory development	The CFTC said on July 9, 2026 that it would stay CME plans for 24/7 crude oil futures trading, while management said it filed under both self-certification and full review routes	Reuters reporting	July 9, 2026
CEO transition	Terry Duffy remains Chairman and CEO, and President and CFO Lynne Fitzpatrick is the announced successor who was congratulated on the promotion during the Q2 2026 call	CME Group company profile and Q2 2026 earnings call	July 22, 2026

Frequently Asked Questions

Read the CBOE AI stock analysis Compare financial stocks with the AI Stock Picker View ICE AI stock forecast Explore BAC AI technical analysis Open the AI Stock Picker Build a trading strategy

This CME AI stock analysis page is an informational research tool, not investment advice, a recommendation, or a guarantee of future returns. Forecast ranges are scenarios based on available public data, valuation assumptions, and technical snapshots as of the data cutoff, and they may be wrong.